Browsing Tag

matches

3 posts
Benralizumab Matches Mepolizumab for Rare Vasculitis thumbnail

Benralizumab Matches Mepolizumab for Rare Vasculitis

Meeting Coverage > AAAAI — Similar rates of patients with eosinophilic granulomatosis with polyangiitis achieved remission by Elizabeth Short, Staff Writer, MedPage Today February 23, 2024 WASHINGTON -- Treatment with benralizumab (Fasenra) was noninferior to mepolizumab (Nucala) for relapsing or refractory eosinophilic granulomatosis with polyangiitis (EGPA), the randomized MANDARA trial showed. Among 140 patients receiving
Read More
Index Of News